α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines

• Главные авторы: Xiao-Feng Xu (Автор), Guo-Xiong Liu (Автор), Cong Zhu (Автор), Xi-Min Qiao (Автор), Shao-Fu Yu (Автор), Tong Deng (Автор), Ying-Hui Jin (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2020-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

ObjectiveTo systematically evaluate the quality of clinical practice guidelines (CPG) for medically treating benign prostatic hyperplasia (BPH), and to compare the context of recommendations in order to provide references for clinical application.MethodsWe searched databases of National Guideline Cl...